Gestational trophoblastic tumours (GTT) are a rare but pregnancy related tumours arising from the placenta

Methotrexate chemotherapy is the sstandard treatment option for low risk GTT tumours .

A new regimen was unveiled at the ESMO European Society of Medical Oncology Congress-2024, Barcelona.

A French trial reported promising results using combination of chemotherapy ( Methotrexate) and immunotherapy (Avelumab)

Disclaimer: Please note – This blog is NOT medical advice. This blog is NOT a expert medical opinion on various topics. This blog is purely for information only and do check the sources where cited. Please DO consult your own doctor to discuss concerns and options relevant to you. The views expressed in this blog are NOT, in any way whatsoever, intended to be a substitute for professional advice. The blog is NOT previewed, commissioned or otherwise endorsed, in any way, by any organisation that the author is associated with. The views expressed in this blog likely represents some of the author’s personal views held at the time of drafting the blog and MAY CHANGE overtime, particularly when new evidence comes to light.